Novartis today announced results from a validation study of the innovative, algorithm-based digital solution MS Progression Discussion Tool, or MSProDiscussTM. The tool aims to support and facilitate a discussion between physicians and patients living with multiple sclerosis (MS) who have transitioned, or are at risk of transitioning from relapsing remitting MS (RRMS) to secondary progressive MS (SPMS)[1].
For summer season, Croatia will dispense ePrescriptions for Finnish citizens and allow the access of Czech patient summaries, while Croatians travelling Estonia can get their ePrescriptions dispensed there. These exchanges will now be possible as the eHealth Network, comprising e-health agencies in Europe, agreed on 2 April 2019 that